What is the market capitalization of Nuvation Bio Inc.?

Nuvation Bio Inc. (NUVB) has a market capitalization of approximately 1,638,793,303 USD.

How many ETFs hold NUVB?

NUVB is held by 51 ETFs tracked on Investir en Bourse.

Where can I buy NUVB in Canada?

NUVB can be purchased through any Canadian online broker including Wealthsimple, Questrade, Qtrade, or RBC Direct Investing.

NUVB

Nuvation Bio Inc.

Nuvation Bio Inc. (NUVB) is an American company in the healthcare sector, listed on NYSE. Market capitalization of 1.6 billion USD (small-cap).

Details

Price4.72 USD

Market cap1.64 G USD

Payout ratio0.00%

ROE-39.51%

Debt / Equity67.90%

SectorHealthcare

Websitenuvationbio.com

Updated 2h ago

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo. The company was founded in 2018 and is headquartered in New York, New York.